saizen 5,83 mg/ml süstelahus kolbampullis
merck serono s.p.a. - somatropiin - süstelahus kolbampullis - 5,83mg 1ml 1.03ml 1tk; 5,83mg 1ml 1.03ml 5tk
saizen 8 mg click.easy süstelahuse pulber ja lahusti
merck serono s.p.a. - somatropiin - süstelahuse pulber ja lahusti - 24tÜ 5tk; 24tÜ 1tk
recreol kreem
grindeks as - dekspantenool - kreem - 50mg 1g 30g 1tk; 50mg 1g 50g 1tk
recreol salv
grindeks as - dekspantenool - salv - 50mg 1g 50g 1tk; 50mg 1g 30g 1tk
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - mitu müeloomit - antineoplastilised ained - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
voxzogo
biomarin international limited - vosoritide - achondroplasia - narkootikumid luuhaiguste raviks - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.
cefuroxime venus pharma süste-/infusioonilahuse pulber
venus pharma gmbh - tsefuroksiim - süste-/infusioonilahuse pulber - 750mg 1tk
cefuroxime venus pharma süste-/infusioonilahuse pulber
venus pharma gmbh - tsefuroksiim - süste-/infusioonilahuse pulber - 1,5g 1tk
ceftriaxone venus pharma süste-/infusioonilahuse pulber
venus pharma gmbh - tseftriaksoon - süste-/infusioonilahuse pulber - 2g 10tk; 2g 1tk; 2g 5tk
ceftriaxone venus pharma süste-/infusioonilahuse pulber
venus pharma gmbh - tseftriaksoon - süste-/infusioonilahuse pulber - 1g 1tk; 1g 10tk